Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Technologies, Thomas Scientific Ink Distribution Agreement for Genomics Products

NEW YORK ─ Thomas Scientific said on Tuesday that it has inked a strategic distribution agreement with Agilent Technologies that expands its molecular biology product portfolio.

Under the deal, Thomas Scientific will provide its customers with access to more than 700 bioreagent products from the genomics division of Santa Clara, California-based Agilent, including qPCR instruments, PCR enzymes, and other molecular biology reagents. To help satisfy growing demands from high complexity laboratories, Agilent's CRISPR libraries will also be available through Thomas Scientific.

Financial and other terms of the deal were not disclosed.

Swedesboro, New Jersey-based Thomas Scientific noted that from the time of its acquisition by the Carlyle Group in 2017, it has completed four strategic acquisitions that have helped it expand the reach of its distribution network. It also has other distribution agreements, including with MicroGEM, Reditus Laboratories, and Microbix Biosystems.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.